87 related articles for article (PubMed ID: 38355287)
1. Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options.
Gao H; Xi Z; Dai J; Xue J; Guan X; Zhao L; Chen Z; Xing F
Mol Cancer; 2024 May; 23(1):88. PubMed ID: 38702734
[TBL] [Abstract][Full Text] [Related]
2. Variety in the USP deubiquitinase catalytic mechanism.
Keijzer N; Priyanka A; Stijf-Bultsma Y; Fish A; Gersch M; Sixma TK
Life Sci Alliance; 2024 Apr; 7(4):. PubMed ID: 38355287
[TBL] [Abstract][Full Text] [Related]
3. Contribution of active site residues to substrate hydrolysis by USP2: insights into catalysis by ubiquitin specific proteases.
Zhang W; Sulea T; Tao L; Cui Q; Purisima EO; Vongsamphanh R; Lachance P; Lytvyn V; Qi H; Li Y; Ménard R
Biochemistry; 2011 May; 50(21):4775-85. PubMed ID: 21542621
[TBL] [Abstract][Full Text] [Related]
4. The structure of the deubiquitinase USP15 reveals a misaligned catalytic triad and an open ubiquitin-binding channel.
Ward SJ; Gratton HE; Indrayudha P; Michavila C; Mukhopadhyay R; Maurer SK; Caulton SG; Emsley J; Dreveny I
J Biol Chem; 2018 Nov; 293(45):17362-17374. PubMed ID: 30228188
[TBL] [Abstract][Full Text] [Related]
5. The WD40-repeat protein-containing deubiquitinase complex: catalysis, regulation, and potential for therapeutic intervention.
Villamil MA; Liang Q; Zhuang Z
Cell Biochem Biophys; 2013 Sep; 67(1):111-26. PubMed ID: 23797609
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders.
Kitamura H
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834633
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the 'Fingers' subdomain of the deubiquitinase USP1 modulate its function and activity.
Olazabal-Herrero A; García-Santisteban I; Rodríguez JA
FEBS J; 2016 Mar; 283(5):929-46. PubMed ID: 26758085
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for ubiquitin/Fubi cross-reactivity in USP16 and USP36.
O'Dea R; Kazi N; Hoffmann-Benito A; Zhao Z; Recknagel S; Wendrich K; Janning P; Gersch M
Nat Chem Biol; 2023 Nov; 19(11):1394-1405. PubMed ID: 37443395
[TBL] [Abstract][Full Text] [Related]
9. UniProt: the Universal Protein Knowledgebase in 2023.
UniProt Consortium
Nucleic Acids Res; 2023 Jan; 51(D1):D523-D531. PubMed ID: 36408920
[TBL] [Abstract][Full Text] [Related]
10. Cryo-EM reveals a mechanism of USP1 inhibition through a cryptic binding site.
Rennie ML; Arkinson C; Chaugule VK; Walden H
Sci Adv; 2022 Sep; 8(39):eabq6353. PubMed ID: 36170365
[TBL] [Abstract][Full Text] [Related]
11. Mitoxantrone stacking does not define the active or inactive state of USP15 catalytic domain.
Priyanka A; Tisi D; Sixma TK
J Struct Biol; 2022 Sep; 214(3):107862. PubMed ID: 35605756
[TBL] [Abstract][Full Text] [Related]
12. Structural Insights into the Catalytic Mechanism and Ubiquitin Recognition of USP34.
Xu G; Su H; Lu L; Liu X; Zhao L; Tang B; Ming Z
J Mol Biol; 2022 Jul; 434(13):167634. PubMed ID: 35588869
[TBL] [Abstract][Full Text] [Related]
13. Investigation of USP30 inhibition to enhance Parkin-mediated mitophagy: tools and approaches.
Tsefou E; Walker AS; Clark EH; Hicks AR; Luft C; Takeda K; Watanabe T; Ramazio B; Staddon JM; Briston T; Ketteler R
Biochem J; 2021 Dec; 478(23):4099-4118. PubMed ID: 34704599
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
